NANO MRNA Co.,Ltd.

4571.T · JPX
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Market Cap¥10,154¥12,789¥16,822¥18,049
- Cash¥1,707¥2,078¥2,812¥3,545
+ Debt¥540¥1,109¥1,109¥1,150
Enterprise Value¥8,987¥11,821¥15,119¥15,654
Revenue¥109¥136¥202¥264
% Growth-19.9%-33%-23.4%
Gross Profit¥78¥111¥160¥223
% Margin72%81.9%78.9%84.4%
EBITDA-¥833-¥863-¥1,246-¥2,058
% Margin-767.2%-636.9%-616.2%-779.4%
Net Income-¥835-¥780-¥1,311-¥1,882
% Margin-769.8%-575.6%-648.4%-712.7%
EPS Diluted-11.85-11.1-18.7-26.9
% Growth-6.8%40.6%30.5%
Operating Cash Flow-¥402-¥585-¥1,087-¥1,753
Capital Expenditures¥402¥0¥0-¥6
Free Cash Flow¥0-¥585-¥1,087-¥1,759
NANO MRNA Co.,Ltd. (4571.T) Financial Statements & Key Stats | AlphaPilot